1. Modulatory Role of Single Nucleotide Polymorphisms of Distinct Genetic Pathways on Clinical Behavior of Medullary Thyroid Carcinoma

Volume 21, Issue 5, May 2020, Pages 1289-1293

Vasudha Mishra; Pradnya Kowtal; Pallavi Rane; Rajiv Sarin

• View Article
• PDF 278.84 K

2. Plasma Calcitonin Levels and miRNA323 Expression in Medullary Thyroid Carcinoma Patients with or without RET Mutation

Volume 18, Issue 8, August 2017, Pages 2179-2184

Samira Ehyaei; Mehdi Hedayati; Marjan Zarif Yeganeh; Sara Sheikholeslami; Mahsa Ahadi; Sayed Asadollah Amini

• View Article
• PDF 323.43 K

3. High Affinity Pharmacological Profiling of Dual Inhibitors Targeting RET and VEGFR2 in Inhibition of Kinase and Angiogeneis Events in Medullary Thyroid Carcinoma

Volume 16, Issue 16, December 2015, Pages 7089-7095

• View Article
• PDF 1.25 MB